Results 81 to 90 of about 225,165 (200)

Pituitary Pars Intermedia Dysfunction and Metabolic Syndrome in Donkeys

open access: yesAnimals, 2020
Appropriate medical care for donkeys is challenging despite being important working animals in non-industrialized countries and pets in first world countries.
Heidrun Gehlen   +4 more
doaj   +1 more source

Analgesic effects of alpha‐2‐adrenoreceptor agonists in equine medicine: systemic, spinal, and local applications

open access: yesEquine Veterinary Education, EarlyView.
Summary Alpha‐2‐adrenoreceptor agonists provide analgesia when used as sole agents but can also be used in combination with other drugs for their additive and potentially synergistic effects. Further, because of their effects on blood flow, alpha‐2‐adrenoreceptor agonists act to extend and perhaps intensify the effects of drugs, such as local ...
J. Brandly   +4 more
wiley   +1 more source

Metabogenomics reveals four candidate regions involved in the pathophysiology of Equine Metabolic Syndrome.

open access: yes, 2020
An analogous condition to human metabolic syndrome, Equine Metabolic Syndrome (EMS) is defined by several clinical signs including obesity, hyperinsulinemia, and peripheral insulin dysregulation (ID).
Patterson Rosa, L
core   +2 more sources

Association of sustained supraphysiologic hyperinsulinemia and inflammatory signaling within the digital lamellae in light‐breed horses

open access: yesJournal of Veterinary Internal Medicine, 2019
Background Hyperinsulinemia is associated with equine laminitis, and digital lamellar inflammation in equine metabolic syndrome‐associated laminitis (EMSAL) is modest when compared with sepsis‐associated laminitis.
Mauria R. Watts   +4 more
doaj   +1 more source

Equine glucagon-like peptide-1 receptor physiology [PDF]

open access: yesPeerJ, 2018
Background Equine metabolic syndrome (EMS) is associated with insulin dysregulation, which often manifests as post-prandial hyperinsulinemia. Circulating concentrations of the incretin hormone, glucagon-like peptide-1 (GLP-1) correlate with an increased ...
Murad H. Kheder   +4 more
doaj   +2 more sources

The Cladophora glomerata Enriched by Biosorption Process in Cr(III) Improves Viability, and Reduces Oxidative Stress and Apoptosis in Equine Metabolic Syndrome Derived Adipose Mesenchymal Stromal Stem Cells (ASCs) and Their Extracellular Vesicles (MV's). [PDF]

open access: yesMar Drugs, 2017
This study investigated in vitro effects of freshwater alga Cladophora glomerata water extract enriched during a biosorption process in Cr(III) trivalent chromium and chromium picolinate on adipose-derived mesenchymal stromal stem cells (ASCs) and ...
Marycz K   +4 more
europepmc   +2 more sources

Mitral regurgitation and decompensated heart failure in a young pregnant pony mare: An aetiological challenge

open access: yesEquine Veterinary Education, EarlyView.
Summary A 4‐year‐old, 6‐month pregnant, Welsh pony mare presented with severe acute clinical signs including depression, anorexia, pale mucous membranes, tachycardia with a grade 4/6 holosystolic murmur and moderate expiratory dyspnoea with diffuse wheezes. There was no evidence of placentitis or fetal distress.
M. F. David   +4 more
wiley   +1 more source

Identifying equine metabolic syndrome in New Zealand [PDF]

open access: yes, 2021
FALS
Logan M, Bolwell C, Gee E, Mayhew IG
core  

Effects of resveratrol and its analogues on the cell cycle of equine mesenchymal stem/stromal cells

open access: yes, 2023
Resveratrol (RSV; trans-3,5,4′-trihydroxystilbene) strongly activates sirtuin 1, and it and its analogue V29 enhance the proliferation of mesenchymal stem/stromal cells (MSCs).
TAMURA, Norihisa   +9 more
core   +1 more source

Updates on intra‐articular corticosteroid administration in horses

open access: yesEquine Veterinary Education, EarlyView.
Summary Intra‐articular (IA) corticosteroid administration in equine athletes has gained increased attention recently, particularly in racing. Despite widespread corticosteroid use in equine practice for decades, there are still a lack of equine‐specific studies to address key questions related to their use.
K. Tanner   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy